LENSTEC, INC.
ST PETERSBURG, FLORIDA

Lenstec, Inc. is a prominent medical device corporation based in Florida, established in 1993. As an ISO 13485 compliant enterprise, Lenstec is recognized for manufacturing CE Marked products that adhere to rigorous international standards. The company holds an esteemed position within the global ophthalmic surgical market by offering advanced intraocular lenses (IOLs) utilized across more than 60 countries. Located in St. Petersburg, Florida, with additional operations in the United Kingdom and a major manufacturing facility of 30,000 sq. ft. in Barbados designed to exceed medical device standards, Lenstec's global footprint extends its reach to numerous markets effectively. The company achieved significant milestones by receiving two U.S. FDA approvals for its Softec implants within a short span in 2010. The product range of Lenstec includes innovative solutions such as the Softec HD family that provides monofocal IOLs with unmatched precision, the state-of-the-art SBL-3 Segmented Bifocal Lens enhancing human-like vision through superior contrast sensitivity, and the Softec Aspheric Posterior Chamber Intraocular Lens for post-phacoemulsification cataract patients. These products highlight Lenstec's commitment to advancing ophthalmic surgery techniques. Guided by Chief Executive Officer John Clough and supported by Secretary Jennifer Gee, Lenstec continues its mission to deliver groundbreaking advancements in eye care solutions. The company stands as a distinguished name with registered trademarks such as Softec, Tetraflex, and SBL-3. For more information about their portfolio of ophthalmic products or corporate details, the public is directed to visit lenstec.com.